bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today shared another compelling patient case study in which ...

Daiichi Sankyo announced that the first patient has been dosed in the global phase 3 TROPION-Lung17 trial. The study is evaluating DATROWAY in patients with locally advanced or metastatic nonsquamous ...

LOS ANGELES (KABC) -- A stage four lung cancer patient has been transferred to Chicago for a double-lung transplant just days after his insurance company reversed its decision. Deron Wells' story ...

A new study finds Black Medicare beneficiaries with early-stage non–small cell lung cancer (NSCLC) continues to receive curative treatment at lower rates than White patients, highlighting ongoing ...

Severe COVID-19 and influenza infections prime the lungs for cancer and can accelerate the disease's development, but vaccination heads off those harmful effects, new research from UVA Health's Beirne ...

A UVA Health study finds severe viral infections can prime the lungs for cancer, but vaccination appears to reduce that risk.

A new project at Penn Medicine in Philadelphia is trying to use big data to keep lung cancer patients out of the emergency room. By using a variety of measures such as recent lab tests and data culled ...

Five-year survival rates are among the lowest of all cancers, at about 25%. But when caught early enough – through annual CT ...

Severe COVID or flu may quietly raise lung cancer risk—but vaccines appear to stop the damage before it starts.

Thanks to recent therapy advances, the lung cancer mortality rate has declined and survival rates have improved. Many factors influence the likelihood of a lung cancer cure or long-term survival, ...

It can be surprising to learn that lung cancer can develop in people who have never smoked. In fact, up to 20% of lung ...